The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Cubist Pharmaceuticals Inc.  (CBST) Trade Now »     Rate CBST  -  Discuss CBST  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate CBST:



CBST Analysis & Videos »


CBST: Bull or Bear?

FDA Calendar Updates: KG, PTIE, DRRX, ALTH, TRIB, CBST, DYAX Graphic_rating_buy CBST
Mikerun
73%
 -2.09%
in 149 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 243 entries as of 7/7/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending...
By  Mike Havrilla   (+1.04%  risk: conservative)  07/07/09 Comment


EU approves Cubicin Graphic_rating_buy CBST
20105205_1_
75%
 -32.14%
in 383 days

EU approves Novartis' Cubicin to treat hospital infections

FDLI SmartBrief | 11/07/2008

The European Union has approved Cubicin for expanded use in patients suffering from potentially fatal infections commonly contracted during hospital stays. The two new indications approved were right-sided infective endocarditis due to Staphylococcus aureus, an infection of the heart valve, and Staphylococcus aureus bacteremia, a bloodstream infection. Reuters (09/05)

By  ariesdragon   (+20.82%  risk: conservative)  11/14/08 Comment


Bullish on CBST ... Graphic_rating_buy CBST
Foto
62%
 -13.29%
in 508 days
Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $29 Analysts' Targets Stanford Group Company $34 Buy Wednesday, July 02, 2008 Needham & Co. $24 Buy Tuesday, July 01, 2008 Robert W. Baird & Co. $28 Outperform Tuesday, January 15, 2008 Cubist Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products that address medical needs in the acute care environment in the Untied States, the European Union, Argentina, Canada, India, Israel, Korea...
By  Marian Filo   (-24.55%  risk: aggressive)  07/12/08 Comment


Get free stock alert for CBST:
Your Email Address:





People Bullish on CBST

fannie32
Analyst
N/A
2 mos ago

tully_mars
Analyst
N/A
4 mos ago

Mikerun
Mike Havrilla
Principal
73%
4 mos ago

publiuslex
Analyst
N/A
5 mos ago

20105205_1_
ariesdragon
Analyst
75%
about 1 year ago


People Bearish on CBST

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
AIG American International Group Inc.
JPM JPMorgan Chase & Co
C Citigroup Inc
ETFC E*Trade Financial Corp
FNM Fannie Mae
WMT WalMart Stores Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on CBST


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Cubist Pharmaceuticals Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch